Evidence map›Paper›PMID 40027104›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2025

Integration of phytochemical profiling and computational approaches to evaluate the neuroprotective potential of

Abdul Jalil Shah, Mohammad Younis Dar, Mohd Adnan, Tanmaykumar Varma, Dhairiya Agarwal, Prabha Garg, Reyaz Hassan Mir, Rampratap Meena, Mubashir Hussain Masoodi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Cells · 2025
    Article
  3. From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases.Advances in pharmacological and pharmaceutical sciences · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdul Jalil ShahPharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Jammu and Kashmir, India.
Mohammad Younis DarDrug Standardization Research Unit, Regional Research Institute of Unani medicine (CCRUM), Naseem Bagh campus, University of Kashmir, Srinagar, Jammu and Kashmir, India. 190006.
Mohd AdnanDepartment of Biology, College of Science, University of Ha'il, Ha'il, P.O. Box 2440, Saudi Arabia.
Tanmaykumar VarmaNational Institute of Pharmaceutical Education and Research, S.A.S. Nagar Mohali, 160062, Punjab India.
Dhairiya AgarwalNational Institute of Pharmaceutical Education and Research, S.A.S. Nagar Mohali, 160062, Punjab India.
Prabha GargNational Institute of Pharmaceutical Education and Research, S.A.S. Nagar Mohali, 160062, Punjab India.
Reyaz Hassan MirPharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Jammu and Kashmir, India.
Rampratap MeenaCentral Council for Research in Unani medicine (CCRUM), 61-65, opp. D-Block, Institutional Area, Janakpuri, New Delhi,110058, India.
Mubashir Hussain MasoodiPharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Jammu and Kashmir, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite broad spectrum utility of

Indexed as

GCMSMD simulationsMolecular dockingNardostachys jatamansiNetwork pharmacology

Identifiers

PMID40027104
PMCPMC11872466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.